HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy.

Abstract
A case report of a 16 year old boy in whom selective IgA deficiency progressed to typical common variable immunodeficiency (CVID) is described. This boy with a history of frequent but not severe respiratory tract infections was referred to hospital because of severe pleuropneumonia and decreased levels of IgA (0.23 g/L), but normal IgG and IgM levels. Lymphocyte subpopulation determination revealed a decreased proportion of CD4+ lymphocytes (30%) and an increased proportion of CD8+ lymphocytes (32%), while CD3+, CD19+ and CD16+/56+ subpopulations were normal. During the subsequent 17 months a gradual decrease in IgG (ultimate level 2.23 g/L), IgA (< 0.05 g/L) and IgM (< 0.05 g/L) levels was observed, the decrease in IgM being the slowest reflecting a constant heavy chain gene order on chromosome 14. The observation supports the thesis of a close relation of selective IgA deficiency and common variable immunodeficiency.
AuthorsJ Litzman, M Burianova, V Thon, J Lokaj
JournalAllergologia et immunopathologia (Allergol Immunopathol (Madr)) 1996 Jul-Aug Vol. 24 Issue 4 Pg. 174-6 ISSN: 0301-0546 [Print] Singapore
PMID8939274 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin G
  • Immunoglobulin M
Topics
  • Adolescent
  • Common Variable Immunodeficiency (blood, immunology, therapy)
  • Disease Progression
  • Humans
  • IgA Deficiency (blood, complications, immunology)
  • Immunization, Passive
  • Immunoglobulin G (blood, immunology)
  • Immunoglobulin M (blood, immunology)
  • Male
  • Recurrence
  • Respiratory Tract Infections (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: